BIOMAT Database Logo BIOMAT Database Logo

High expression of c-Myc in chronic lymphocytic leukaemia with t(8;14)(q24.1;q32): A case report. 2020

Keiki Nagaharu, and Takuya Izumi, and Mari Ueda, and Eiji Usui, and Masato Shikami, and Kohshi Ohishi, and Shigehisa Tamaki
Department of Hematology, Ise Red Cross Hospital, Ise, Mie, Japan; Department of Hematology and Oncology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, Japan. Electronic address: keiki-nagaharu@clin.medic.mie-u.ac.jp.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002883 Chromosomes, Human, Pair 14 A specific pair of GROUP D CHROMOSOMES of the human chromosome classification. Chromosome 14
D002898 Chromosomes, Human, Pair 8 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 8
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014178 Translocation, Genetic A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome. Chromosomal Translocation,Translocation, Chromosomal,Chromosomal Translocations,Genetic Translocation,Genetic Translocations,Translocations, Chromosomal,Translocations, Genetic
D015451 Leukemia, Lymphocytic, Chronic, B-Cell A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease. B-Cell Leukemia, Chronic,B-Lymphocytic Leukemia, Chronic,Chronic Lymphocytic Leukemia,Leukemia, B-Cell, Chronic,Leukemia, Lymphocytic, Chronic,Lymphocytic Leukemia, Chronic, B-Cell,Lymphoma, Small Lymphocytic,B-Cell Chronic Lymphocytic Leukemia,B-Cell Malignancy, Low-Grade,Diffuse Well-Differentiated Lymphocytic Lymphoma,Disrupted In B-Cell Malignancy,Leukemia, B Cell, Chronic,Leukemia, Chronic Lymphatic,Leukemia, Chronic Lymphocytic,Leukemia, Chronic Lymphocytic, B-Cell,Leukemia, Lymphoblastic, Chronic,Leukemia, Lymphocytic, Chronic, B Cell,Lymphoblastic Leukemia, Chronic,Lymphocytic Leukemia, Chronic,Lymphocytic Leukemia, Chronic, B Cell,Lymphocytic Lymphoma,Lymphocytic Lymphoma, Diffuse, Well Differentiated,Lymphocytic Lymphoma, Diffuse, Well-Differentiated,Lymphocytic Lymphoma, Well Differentiated,Lymphocytic Lymphoma, Well-Differentiated,Lymphoma, Lymphocytic,Lymphoma, Lymphocytic, Diffuse, Well Differentiated,Lymphoma, Lymphocytic, Diffuse, Well-Differentiated,Lymphoma, Lymphocytic, Well Differentiated,Lymphoma, Lymphocytic, Well-Differentiated,Lymphoma, Lymphoplasmacytoid, CLL,Lymphoma, Small Lymphocytic, Plasmacytoid,Lymphoma, Small-Cell,Lymphoplasmacytoid Lymphoma, CLL,Small-Cell Lymphoma,B Cell Chronic Lymphocytic Leukemia,B Cell Leukemia, Chronic,B Cell Malignancy, Low Grade,B Lymphocytic Leukemia, Chronic,B-Cell Leukemias, Chronic,B-Cell Malignancies, Low-Grade,B-Lymphocytic Leukemias, Chronic,CLL Lymphoplasmacytoid Lymphoma,CLL Lymphoplasmacytoid Lymphomas,Chronic B-Cell Leukemia,Chronic B-Cell Leukemias,Chronic B-Lymphocytic Leukemia,Chronic B-Lymphocytic Leukemias,Chronic Lymphatic Leukemia,Chronic Lymphatic Leukemias,Chronic Lymphoblastic Leukemia,Chronic Lymphoblastic Leukemias,Chronic Lymphocytic Leukemias,Diffuse Well Differentiated Lymphocytic Lymphoma,Disrupted In B Cell Malignancy,Leukemia, Chronic B-Cell,Leukemia, Chronic B-Lymphocytic,Leukemias, Chronic B-Cell,Leukemias, Chronic B-Lymphocytic,Leukemias, Chronic Lymphatic,Leukemias, Chronic Lymphoblastic,Low-Grade B-Cell Malignancies,Low-Grade B-Cell Malignancy,Lymphatic Leukemia, Chronic,Lymphatic Leukemias, Chronic,Lymphoblastic Leukemias, Chronic,Lymphocytic Leukemias, Chronic,Lymphocytic Lymphoma, Small,Lymphocytic Lymphomas,Lymphocytic Lymphomas, Small,Lymphocytic Lymphomas, Well-Differentiated,Lymphoma, CLL Lymphoplasmacytoid,Lymphoma, Small Cell,Lymphoma, Well-Differentiated Lymphocytic,Lymphomas, CLL Lymphoplasmacytoid,Lymphomas, Lymphocytic,Lymphomas, Small Lymphocytic,Lymphomas, Small-Cell,Lymphomas, Well-Differentiated Lymphocytic,Lymphoplasmacytoid Lymphomas, CLL,Malignancies, Low-Grade B-Cell,Malignancy, Low-Grade B-Cell,Small Cell Lymphoma,Small Lymphocytic Lymphoma,Small Lymphocytic Lymphomas,Small-Cell Lymphomas,Well-Differentiated Lymphocytic Lymphoma,Well-Differentiated Lymphocytic Lymphomas
D016271 Proto-Oncogene Proteins c-myc Basic helix-loop-helix transcription factors encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated (constitutive) expression of c-myc proteins can cause tumorigenesis. L-myc Proteins,N-myc Proteins,c-myc Proteins,myc Proto-Oncogene Proteins,p62(c-myc),Proto-Oncogene Products c-myc,Proto-Oncogene Proteins myc,myc Proto-Oncogene Product p62,p62 c-myc,L myc Proteins,N myc Proteins,Proteins myc, Proto-Oncogene,Proto Oncogene Products c myc,Proto Oncogene Proteins c myc,Proto Oncogene Proteins myc,Proto-Oncogene Proteins, myc,c myc Proteins,myc Proto Oncogene Product p62,myc Proto Oncogene Proteins,myc, Proto-Oncogene Proteins,p62 c myc

Related Publications

Keiki Nagaharu, and Takuya Izumi, and Mari Ueda, and Eiji Usui, and Masato Shikami, and Kohshi Ohishi, and Shigehisa Tamaki
A t(8;14)(q24.1;q32) in Plasma Cell Myeloma: A Case Report and Literature Review.
January 2020, Journal of the Association of Genetic Technologists,
Keiki Nagaharu, and Takuya Izumi, and Mari Ueda, and Eiji Usui, and Masato Shikami, and Kohshi Ohishi, and Shigehisa Tamaki
Occurrence of trisomy 12, t(14;18)(q32;q21), and t(8;14)(q24.1;q11.2) in a patient with B-cell chronic lymphocytic leukemia.
September 2008, Cancer genetics and cytogenetics,
Keiki Nagaharu, and Takuya Izumi, and Mari Ueda, and Eiji Usui, and Masato Shikami, and Kohshi Ohishi, and Shigehisa Tamaki
The t(8;14)(q24.1;q32) and its variant translocations: A study of 34 cases.
September 2017, Hematology/oncology and stem cell therapy,
Keiki Nagaharu, and Takuya Izumi, and Mari Ueda, and Eiji Usui, and Masato Shikami, and Kohshi Ohishi, and Shigehisa Tamaki
Chronic lymphocytic leukemia with a t(8;14)(q24;q32): FISHing catches a (sheepish) red herring.
December 2015, American journal of hematology,
Keiki Nagaharu, and Takuya Izumi, and Mari Ueda, and Eiji Usui, and Masato Shikami, and Kohshi Ohishi, and Shigehisa Tamaki
t(11;14)(q13;q32): chronic lymphocytic leukaemia or mantle cell leukaemia?
December 1996, British journal of haematology,
Keiki Nagaharu, and Takuya Izumi, and Mari Ueda, and Eiji Usui, and Masato Shikami, and Kohshi Ohishi, and Shigehisa Tamaki
Atypical rearrangement involving 3'-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression.
February 2013, Molecular cytogenetics,
Keiki Nagaharu, and Takuya Izumi, and Mari Ueda, and Eiji Usui, and Masato Shikami, and Kohshi Ohishi, and Shigehisa Tamaki
MYC network mutations in high-risk chronic lymphocytic leukaemia.
September 2014, Hematological oncology,
Keiki Nagaharu, and Takuya Izumi, and Mari Ueda, and Eiji Usui, and Masato Shikami, and Kohshi Ohishi, and Shigehisa Tamaki
Novel identification of t(14;18)(q32;q21)/IGH::MALT1 in chronic lymphocytic leukaemia.
February 2024, British journal of haematology,
Keiki Nagaharu, and Takuya Izumi, and Mari Ueda, and Eiji Usui, and Masato Shikami, and Kohshi Ohishi, and Shigehisa Tamaki
Coexistence of t(2;14;11)(p16.1;q32;q23) and t(14;19)(q32;q13.3) chromosome translocations in a patient with chronic lymphocytic leukemia: A case report.
December 2017, Medicine,
Keiki Nagaharu, and Takuya Izumi, and Mari Ueda, and Eiji Usui, and Masato Shikami, and Kohshi Ohishi, and Shigehisa Tamaki
[Diffuse large B-cell lymphoma mainly involving the heart and showing t(8;14) (q24;q32) with c-myc rearrangement].
September 1997, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!